Marinomed Biotech AG | Finanzwire

Basculer en Français

8299	Companies
114942	Keywords
55348	Articles
62469	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 09/18/2024 at 17:26, 2 months 2 days ago

Marinomed Biotech AG Announces Capital Increase Excluding Subscription Rights

Investors Capital Increase Marinomed Biotech AG Subscription Rights Issue Price
PRESS RELEASE

published on 09/18/2024 at 17:21, 2 months 2 days ago

EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Marinomed Biotech AG resolves capital increase by issuing 154,053 bearer shares at EUR 5 per share, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights Bearer Shares EUR 5
BRIEF

published on 09/15/2024 at 17:54, 2 months 5 days ago

Marinomed Biotech AG Sets Price Range for Capital Increases

Capital Increase Restructuring Share Price Investor Negotiations Marinomed Biotech
PRESS RELEASE

published on 09/15/2024 at 17:49, 2 months 5 days ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 2 months 10 days ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
PRESS RELEASE

published on 09/11/2024 at 07:45, 2 months 10 days ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
BRIEF

published on 09/02/2024 at 17:51, 2 months 18 days ago

Marinomed Biotech AG Evaluates 10% Capital Increase

Investors Shares Capital Increase Restructuring Marinomed
PRESS RELEASE

published on 09/02/2024 at 17:46, 2 months 18 days ago

EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
Marinomed Biotech AG evaluates a possible 10% capital increase excluding statutory subscription rights to finance ongoing costs in restructuring proceedings. Management Board to discuss with selected investors for potential transaction

Capital Increase Management Board Marinomed Biotech AG Restructuring Proceedings Statutory Subscription Rights
BRIEF

published on 08/20/2024 at 18:05, 3 months ago

Marinomed Biotech AG Reports Preliminary Financial Figures for H1 2024

Financial Results Product Development Restructuring Proceedings Q2 Revenue Growth New Partnerships
PRESS RELEASE

published on 08/20/2024 at 18:00, 3 months ago

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
Marinomed Biotech AG reports preliminary financial figures for the first half of 2024, including a decline in revenues compared to 2023. The company aims to stabilize through restructuring and new partnerships

Restructuring Preliminary Results Financial Figures Partnerships Marinomed Biotech AG

Accesswire

Published on 11/21/2024 at 14:15, 18 minutes ago

neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 33 minutes ago

Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 33 minutes ago

Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 33 minutes ago

Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:00, 33 minutes ago

GameSquare's Stream Hatchet Publishes Q3 Report

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 14:16, 17 minutes ago

EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 18 minutes ago

ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 14:00, 33 minutes ago

Form 8.3 - LOYS AG: Learning Technologies Group plc
Published on 11/21/2024 at 13:15, 1 hour 18 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 58 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6

Les Echos

Published on 11/21/2024 at 06:58, 7 hours 35 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 13 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 48 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE